ArticleResearch square2025
NUDT21 Regulates Macrophage Cytokine Responses via Alternative Polyadenylation in ARDS.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Acute respiratory distress syndrome (ARDS) is a life-threatening condition driven by uncontrolled inflammation and immune dysregulation. The post-transcriptional mechanisms that fine-tune macrophage activation in ARDS remain poorly understood. Here, we identify Nudix hydrolase 21 (NUDT21) as a critical regulator of macrophage-mediated inflammation through alternative polyadenylation (APA). NUDT21 was downregulated in macrophages from human and mouse ARDS lungs. Functional studies using macrophage-specific Nudt21 knockout mice (Nudt21
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.